- After landmark deal, AstraZeneca goes to CSPC again in up to $1.7B pactLess than six months after lining up one of the largest biobucks packages in industry history, AstraZeneca is returning to the same Chinese partner for another drug R&D collaboration. The UK…Endpoints · 24d ago↗ source
- STAT+: What does DeGette’s loss mean for pharma?Colorado Democratic Rep. Diana DeGette, who lost her primary, was knowledgeable about biopharma, if not always a friend to the industry.STAT · 25d ago↗ source
- Court halts Colorado price cap on Amgen's blockbuster EnbrelUS District Court Judge Daniel Domenico in Colorado granted Amgen's preliminary injunction to stop a 70% price cap on its blockbuster autoimmune drug Enbrel, arguing that the cap could cause "econo…